StockNews.com initiated coverage on shares of TherapeuticsMD (NYSE:TXMD – Get Rating) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock. Shares of TXMD opened at $0.22 on Wednesday. TherapeuticsMD has a fifty-two week low of $0.18 and a fifty-two week high of $1.39. The business’s 50 day simple […]
